Extracellular S100A1 Protein Inhibits Apoptosis in Ventricular Cardiomyocytes via Activation of the Extracellular Signal-regulated Protein Kinase 1/2 (ERK1/2)
S100A1 is a Ca 2+ -binding protein of the EF-hand type that belongs to the S100 protein family. It is specifically expressed in the myocardium at high levels and is considered to be an important regulator of cardiac contractility. Because the S100A1 protein is released into the extracellular space d...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2003-11, Vol.278 (48), p.48404-48412 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | S100A1 is a Ca 2+ -binding protein of the EF-hand type that belongs to the S100 protein family. It is specifically expressed in the myocardium
at high levels and is considered to be an important regulator of cardiac contractility. Because the S100A1 protein is released
into the extracellular space during ischemic myocardial injury, we examined the cardioprotective potential of the extracellular
S100A1 protein on ventricular cardiomyocytes in vitro . In this report we show that extracellularly added S100A1 protein is endocytosed into the endosomal compartment of neonatal
ventricular cardiomyocytes via a Ca 2+ -dependent clathrin-mediated process. S100A1 uptake protects neonatal ventricular cardiomyocytes from 2-deoxyglucose and oxidative
stress-induced apoptosis in vitro . S100A1-mediated anti-apoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2)
pro-survival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1,
and ERK1/2. In contrast, neither transsarcolemmal Ca 2+ influx via the L-type channel nor protein kinase A activity seems to take part in the S100A1-mediated signaling pathway.
In conclusion, this study provides evidence for the S100A1 protein serving as a novel cardioprotective factor in vitro . These findings warrant speculation that injury-dependent release of the S100A1 protein from cardiomyocytes may serve as
an intrinsic mechanism to promote survival of the myocardium in vivo . |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M308587200 |